Barclays analyst Hassan Al-Wakeel raised the firm’s price target on Smith & Nephew to 1,200 GBp from 1,150 GBp and keeps an Equal Weight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SNN:
- BTIG medical technology analyst to hold analyst/industry conference call
- Smith & Nephew announces commercial launch of its AETOS Shoulder System
- Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
- Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting
- Smith & Nephew unveils expanded sports medicine portfolio
